Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK
α2受体激动剂用于镇静以改善危重症患者的预后(A2B试验):一项在英国开展的多中心3期实用性临床和成本效益随机试验方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-078645
Walsh, Timothy Simon; Aitken, Leanne M; McKenzie, Cathrine A; Boyd, Julia; Macdonald, Alix; Giddings, Annabel; Hope, David; Norrie, John; Weir, Christopher; Parker, Richard Anthony; Lone, Nazir I; Emerson, Lydia; Kydonaki, Kalliopi; Creagh-Brown, Benedict; Morris, Stephen; McAuley, Daniel Francis; Dark, Paul; Wise, Matt P; Gordon, Anthony C; Perkins, Gavin; Reade, Michael; Blackwood, Bronagh; MacLullich, Alasdair; Glen, Robert; Page, Valerie J